In vitro production of foregut stem cells
AssigneeCambridge Enterprise Limited
InventorsLudovic Vallier, Nicholas Hannan
Life of this patent
Estimating the term…
Abstract
This invention relates to the differentiation of pluripotent cells (PSCs) into foregut stem cells (FSCs) using a definitive endoderm induction medium comprising a TGFfi ligand, fibroblast growth factor (FGF), bone morphogenetic protein (BMP) and a PI3K inhibitor to differentiate the pluripotent cells into definitive endoderm cells and a foregut induction medium comprising a TGFβ ligand to differentiate the definitive endoderm cells into foregut stem cells (FSCs). Methods of differentiation, populations of foregut stem cells, culture media and kits are provided.
Claims12
A method for producing a population of foregut stem cells (FSCs) comprising:
- i) providing a population of definitive endoderm cells (DECs), and
- ii) culturing the DECs in a foregut induction medium consisting of a chemically defined nutrient medium supplemented with a TGFβ ligand to produce a population of foregut stem cells (FSCs).
Dependencies are inferred from the claim text.